113 related articles for article (PubMed ID: 31639093)
1. Antiproliferative evaluation of various aminoquinoline derivatives.
Zorc B; Rajić Z; Perković I
Acta Pharm; 2019 Dec; 69(4):661-672. PubMed ID: 31639093
[TBL] [Abstract][Full Text] [Related]
2. Novel urea and bis-urea primaquine derivatives with hydroxyphenyl or halogenphenyl substituents: Synthesis and biological evaluation.
Perković I; Antunović M; Marijanović I; Pavić K; Ester K; Kralj M; Vlainić J; Kosalec I; Schols D; Hadjipavlou-Litina D; Pontiki E; Zorc B
Eur J Med Chem; 2016 Nov; 124():622-636. PubMed ID: 27614409
[TBL] [Abstract][Full Text] [Related]
3. Novel semicarbazides and ureas of primaquine with bulky aryl or hydroxyalkyl substituents: synthesis, cytostatic and antioxidative activity.
Pavić K; Perković I; Cindrić M; Pranjić M; Martin-Kleiner I; Kralj M; Schols D; Hadjipavlou-Litina D; Katsori AM; Zorc B
Eur J Med Chem; 2014 Oct; 86():502-14. PubMed ID: 25203780
[TBL] [Abstract][Full Text] [Related]
4. Insights into the mechanism of antiproliferative effects of primaquine-cinnamic acid conjugates on MCF-7 cells.
Mabeta P; Pavić K; Zorc B
Acta Pharm; 2018 Sep; 68(3):337-348. PubMed ID: 31259699
[TBL] [Abstract][Full Text] [Related]
5. Primaquine and Chloroquine Fumardiamides as Promising Antiplasmodial Agents.
Beus M; Fontinha D; Held J; Rajić Z; Uzelac L; Kralj M; Prudêncio M; Zorc B
Molecules; 2019 Aug; 24(15):. PubMed ID: 31374989
[TBL] [Abstract][Full Text] [Related]
6. Primaquine hybrids as promising antimycobacterial and antimalarial agents.
Pavić K; Perković I; Pospíšilová Š; Machado M; Fontinha D; Prudêncio M; Jampilek J; Coffey A; Endersen L; Rimac H; Zorc B
Eur J Med Chem; 2018 Jan; 143():769-779. PubMed ID: 29220797
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and Characterization of New Series of 1,3-5-Triazine Hydrazone Derivatives with Promising Antiproliferative Activity.
H Al Rasheed HHA; M Malebari AM; A Dahlous KA; El-Faham A
Molecules; 2020 Jun; 25(11):. PubMed ID: 32545272
[TBL] [Abstract][Full Text] [Related]
8. Asymmetric Primaquine and Halogenaniline Fumardiamides as Novel Biologically Active Michael Acceptors.
Rajić Z; Beus M; Michnová H; Vlainić J; Persoons L; Kosalec I; Jampílek J; Schols D; Keser T; Zorc B
Molecules; 2018 Jul; 23(7):. PubMed ID: 30011922
[TBL] [Abstract][Full Text] [Related]
9. Urea and carbamate derivatives of primaquine: synthesis, cytostatic and antioxidant activities.
Simunović M; Perković I; Zorc B; Ester K; Kralj M; Hadjipavlou-Litina D; Pontiki E
Bioorg Med Chem; 2009 Aug; 17(15):5605-13. PubMed ID: 19581098
[TBL] [Abstract][Full Text] [Related]
10. Machine learning prioritizes synthesis of primaquine ureidoamides with high antimalarial activity and attenuated cytotoxicity.
Levatić J; Pavić K; Perković I; Uzelac L; Ester K; Kralj M; Kaiser M; Rottmann M; Supek F; Zorc B
Eur J Med Chem; 2018 Feb; 146():651-667. PubMed ID: 29407988
[TBL] [Abstract][Full Text] [Related]
11. Antiproliferative Properties of 7,8-Ethylene Diamine Chelator-Lipophilic Fluoroquinolone Derivatives Against Colorectal Cancer Cell Lines.
Khaleel S; Al-Hiari Y; Kasabri V; Haddadin R; Albashiti R; Al-Zweri M; Bustanji Y
Anticancer Agents Med Chem; 2022; 22(5):1012-1028. PubMed ID: 34165411
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and potential anti-proliferative activity of some novel 4-aminoquinoline derivatives.
Ghorab MM; Al-Said MS; Arafa RK
Acta Pharm; 2014 Sep; 64(3):285-97. PubMed ID: 25296675
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and in vitro cytotoxicity evaluation of 4-aminoquinoline derivatives.
Zhang H; Solomon VR; Hu C; Ulibarri G; Lee H
Biomed Pharmacother; 2008 Feb; 62(2):65-9. PubMed ID: 17555912
[TBL] [Abstract][Full Text] [Related]
14. Design, Synthesis and Biological Evaluation of Novel Primaquine-Cinnamic Acid Conjugates of the Amide and Acylsemicarbazide Type.
Pavić K; Perković I; Gilja P; Kozlina F; Ester K; Kralj M; Schols D; Hadjipavlou-Litina D; Pontiki E; Zorc B
Molecules; 2016 Nov; 21(12):. PubMed ID: 27916811
[TBL] [Abstract][Full Text] [Related]
15. Anticancer potential of ascorbic acid and inorganic selenium on human breast cancer cell line MCF-7 and colon carcinoma HCT-116.
Ganash MA
J Cancer Res Ther; 2021; 17(1):122-129. PubMed ID: 33723142
[TBL] [Abstract][Full Text] [Related]
16. Primaquine homodimers as potential antiplasmodial and anticancer agents.
Pavić K; Rubinić B; Rajić Z; Fontinha D; Prudêncio M; Uzelac L; Kralj M; Held J; Zorc B
Bioorg Med Chem Lett; 2019 Oct; 29(19):126614. PubMed ID: 31431364
[TBL] [Abstract][Full Text] [Related]
17. Aminoquinoline derivatives with antiproliferative activity against melanoma cell line.
Nam BS; Kim H; Oh CH; Lee SH; Cho SJ; Sim TB; Hah JM; Kim DJ; Choi JH; Yoo KH
Bioorg Med Chem Lett; 2009 Jul; 19(13):3517-20. PubMed ID: 19464887
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antiproliferative activity of 4-substituted-piperazine-1-carbodithioate derivatives of 2,4-diaminoquinazoline.
Cao SL; Han Y; Yuan CZ; Wang Y; Xiahou ZK; Liao J; Gao RT; Mao BB; Zhao BL; Li ZF; Xu X
Eur J Med Chem; 2013 Jun; 64():401-9. PubMed ID: 23665106
[TBL] [Abstract][Full Text] [Related]
19. Effects of phosphorylation of immunomodulatory agent FTY720 (fingolimod) on antiproliferative activity against breast and colon cancer cells.
Nagaoka Y; Otsuki K; Fujita T; Uesato S
Biol Pharm Bull; 2008 Jun; 31(6):1177-81. PubMed ID: 18520051
[TBL] [Abstract][Full Text] [Related]
20. Chloroquine Urea Derivatives: Synthesis and Antitumor Activity in Vitro.
Rajić KPZ; Mlinarić Z; Uzelac L; Kralj M; Zorc B
Acta Pharm; 2018 Dec; 68(4):471-483. PubMed ID: 31259711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
